Coffee and Agave Inulin Drink for Appetite Control in Obesity
Coffee and agave inulin-based beverage (A)
+ Control beverage (B)
Body Weight+5
+ Nutrition Disorders
+ Nutritional and Metabolic Diseases
Basic Science Study
Summary
Study start date: June 24, 2024
Actual date on which the first participant was enrolled.This study aims to explore the effects of a new drink made from coffee and agave inulin on appetite, dietary habits, and health markers in people with obesity in Mexico. Obesity rates have been rising significantly in the country, and there is a need for effective interventions. Coffee is widely consumed in Mexico and has various health benefits, while agave inulin is known for its positive effects on gut health. This research seeks to determine if a beverage combining these ingredients can help control appetite and improve health, providing a healthier alternative to sugary drinks commonly consumed in Mexico. Participants in this trial will consume the experimental beverage or a placebo drink daily, 30 minutes before breakfast, over two separate two-week periods. The study uses a double-blind, randomized crossover design, meaning neither the participants nor the researchers know who receives which beverage during each period. There will be a two-week break between each phase to clear any lingering effects. Participants will attend six sessions at a designated hospital, where their appetite, food intake, and biochemical markers will be monitored and evaluated to assess the drink's impact.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.30 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Basic Science Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 25 to 55 Years
Range of ages for which participants are eligible to join.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Group I
Active ComparatorGroup II
Active ComparatorStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location